Medical & Scientific Staff

Medical & Scientific Staff

We have one of the largest medical and scientific teams in the United States, dedicated to providing comprehensive, high-quality results and personalized consultative services.

Our experienced staff of pathologists, cytogeneticists, and molecular geneticists offers unparalleled expertise in the field of complex tumor analysis and difficult-to-diagnose malignancies. As a leading laboratory focused on client communication and optimal patient care, our medical and scientific staff is readily available for consultation on any complex case or diagnostic challenge.

Choose the location below to learn more about our medical and scientific staff

  • Ronald W. Thomason, MD

    Medical Director, Brentwood
    Discipline Director, Hematopathology, LabCorp

    Dr. Thomason is board certified in anatomic and clinical pathology and hematopathology. He earned his medical degree with highest honors from the University of Tennessee School of Medicine. He completed residency training in anatomic and clinical pathology at Wilford Hall Medical Center at Lackland Air Force Base in Texas and completed a hematopathology fellowship directed by Dr. Peter Banks at the University of Texas Health Science Center at San Antonio.

    Dr. Thomason has practiced pathology since 1995. He practiced general pathology with an emphasis in hematopathology from 1995-2002, and since 2002 he has practiced hematopathology. Previously, Dr. Thomason was director of hematology and staff pathologist in the Department of Pathology at Blount Memorial Hospital, Maryville, Tenn, and medical director of Molecular Pathology Laboratory, also in Maryville, Tenn.

    Dr. Thomason is a member of the American Society of Clinical Pathology, the American Society of Hematology, and the International Society for Analytic Cytometry.

  • Guangyu Gu, MD

    Director, Cytogenetics Oncology

    Dr. Gu is board certified in clinical cytogenetics.  He earned his medical degree and completed a residency in anatomic pathology from the Fourth Military Medical University (Medicine), China.  Dr. Gu completed a fellowship (Research) in urological surgery at Vanderbilt University, Nashville, TN and in clinical cytogenetics at the University of Utah, Salt Lake City.  In addition to authoring a number of peer-reviewed journal articles and abstracts, Dr. Gu has given poster and oral presentations at multiple national meetings as well as co-authoring several textbook chapters.  He is a member of the College of American Pathologists and American Association for Clinical Chemistry, and a Fellow of the American College of Medical Genetics and Genomics.

  • Ron Lee, MD

    Anatomic pathology, clinical pathology, and hematology

    Dr. Lee is board certified in anatomic pathology, clinical pathology, and hematology (pathology). He earned his medical degree from the University of Florida. After serving in the Air Force as a flight surgeon, Dr. Lee completed residency in anatomic and clinical pathology and a fellowship in hematopathology. Dr. Lee is a member of the American Society for Clinical Pathology, the American Society of Hematology, the Clinical Cytometry Society, the International Society for Advancement of Cytometry, and the United States and Canadian Academy of Pathology.

  • Stephanie J. McAlhany, MD, PhD

    Anatomic pathology, hematology, and cytopathology

    Dr. McAlhany is board certified in anatomic pathology, hematology, and cytopathology. She earned her medical degree and PhD in molecular/cell biology from Baylor College of Medicine. She completed her residency in anatomic pathology at the University of California, San Francisco (UCSF), where she then completed fellowships in surgical pathology, hematopathology, and cytopathology. Dr. McAlhany is a member of the United States and Canadian Academy of Pathologists, the College of American Pathologists, the American Society for Clinical Pathology, and the Alpha Omega Alpha Honor Medical Society.

  • Leticia Miravalle, PhD

    Director, Cytogenetics and Molecular Oncology

    Dr. Miravalle is board certified in Clinical Cytogenetics and in Clinical Molecular Genetics by the American Board of Medical Genetics and Genomics (ABMGG), and in Molecular Diagnostics by the American Board of Clinical Chemistry (ABCC).  She earned her PhD degree in Biochemistry from the National University of La Plata-Buenos Aires, Argentina. Prior to completing her clinical fellowship in Clinical Cytogenetics and Clinical Molecular Genetics at Indiana University School of Medicine, Indianapolis, under the direction of Dr. Gail Vance, she trained in the laboratory of Dr. Bernardino Ghetti at the Indiana Alzheimer Disease Center, Indianapolis, studying the genetics of neurodegenerative disorders.  She is a fellow of the American College of Medical Genetics and Genomics and a member of the Association for Molecular Pathology. 

  • Debra M. Mitchell Nelson, MD

    Anatomic pathology, clinical pathology, and hematology

    Dr. Nelson is board certified in anatomic pathology, clinical pathology, and hematology. She earned her medical degree from the University of the West Indies Faculty of Medicine. She completed her residency in pathology and a hematopathology fellowship at the University of Florida. Dr. Nelson is a member of the American Society for Clinical Pathology and the College of American Pathologists.

  • Christian Morosan, MD

    Anatomic pathology, clinical pathology, and hematology

    Dr. Morosan is board certified in anatomic pathology, clinical pathology, and hematology. He earned his medical degree from the “Carol Davila” University of Medicine and Pharmacy in Bucharest, Romania, and received post-medical school training in family medicine at County Hospital Suceava, Romania. He completed his residency in anatomic and clinical pathology at Tufts New England Medical Center and a hematopathology fellowship at Shands Medical Center-University of Florida. Dr. Morosan is a member of the American Society for Clinical Pathology, the College of American Pathologists, the International Academy of Pathology, the Society of Hematopathologists, and the United States and Canadian Academy of Pathology.

  • Krishna Oza, MD

    Anatomic pathology, clinical pathology, hematology

    Dr. Oza is board certified in anatomic pathology, clinical pathology, hematology, and blood banking/transfusion medicine. He earned his medical degree from Devi Ahilya Vishwa Vidyalaya/M.G.M. Medical College, Indore (M.P.), India. He was a hematology resident at Service Central d’ Hématologie-Immunologie-Hôpital Henri Mondor, Créteil, France, and completed his residency in anatomic and clinical pathology at Beth Israel Medical Center. Dr. Oza completed a fellowship in hematopathology, blood banking, and transfusion medicine at Upstate Medical University in Syracuse, New York. He is a fellow of the American Society for Clinical Pathologists and the College of American Pathologists, as well as a member of the American Society for Clinical Pathologists, and the American Society of Hematology.

  • Joseph S. Papiez, MD

    Anatomic pathology, clinical pathology, and hematology

    Dr. Papiez is board certified in anatomic pathology, clinical pathology, and hematology. He earned his medical degree from the Indiana University School of Medicine. He completed his residency in pathology and a fellowship in hematopathology, directed by Dr Raul Braylan, at the University of Florida. Dr. Papiez is a member of the American Society for Clinical Pathology, the College of American Pathologists, and the Clinical Cytometry Society.

  • Stephanie R. Schreiner, MD

    Anatomic pathology, clinical pathology, and hematology

    Dr. Schreiner is board certified in anatomic pathology, clinical pathology, and hematology. She earned her medical degree from the University of Connecticut School of Medicine. She completed her residency in pathology and a hematopathology fellowship at Johns Hopkins Hospital. Dr. Schreiner is a member of the American Society of Clinical Pathology, the College of American Pathologists, the Society for Hematopathology, the Clinical Cytometry Society, and the United States and Canadian Academy of Pathology.

  • Wlodek Szczarkowski, MD

    Flow Cytometry

    Dr. Szczarkowski earned his medical degree from the Jagiellonian University in Krakow, Poland. He completed his residency in clinical pathology at Berkshire Medical Center in Massachusetts, a hematopathology fellowship at Harvard University and William Beaumont Hospital, and a molecular pathology fellowship at the University of Pennsylvania. Dr. Szczarkowski is one of the nation’s leading experts in flow cytometry.

  • Patricia Uherova, MD

    Anatomic pathology, clinical pathology, and hematology 

    Dr. Uherova is board certified in anatomic pathology, clinical pathology, and hematology. She earned her medical degree from the Charles University School of Medicine in Prague, Czechoslovakia. She completed her residency in pathology at the University of Michigan and hematopathology fellowships at the University of Michigan and Vanderbilt University. Dr. Uherova is a member of the American Society for Clinical Pathology and the United States and Canadian Academy of Pathology.

  • Xiao Xiang Zhang, MD, PhD

    Technical Director, Cytogenetics and Molecular Oncology

    Dr. Zhang is board certified in clinical cytogenetics (ABMGG) and Molecular Diagnostics (ABB).  She earned a PhD in pathology/cytogenetics from McGill University, Canada and a medical degree from Hunan Medical University, China. She completed a fellowship in clinical cytogenetics and molecular genetics at Duke University Medical Center, North Carolina.  Dr. Zhang has co-authored more than 30 articles and abstracts that have appeared in peer-reviewed publications and presented at national meetings.  She holds memberships with the American Board of Medical Genetics and Association for Molecular Pathology, is an inspector and team leader for the College of American Pathologists, and is an invited idem writer for genetics specialty examination, American Board of Medical Genetics and American Board of Bioanalysis.

  • Jonathan L. Klein, MD

    Medical Director, Integrated Oncology and Dianon Pathology, Shelton

    Dr. Klein is board certified in anatomic and clinical pathology, hematopathology and molecular genetic pathology.  He earned his medical degree from Sackler School of Medicine, New York State program, Tel Aviv, Israel. He completed his residency in Anatomic and Clinical Pathology at Winthrop University Hospital, Mineola NY, where he served as chief resident and performed his fellowship training in Hematopathology and Molecular Genetic Pathology at Washington University – Barnes Jewish Hospital, St. Louis MO.  Dr. Klein previously served as laboratory director and chief medical officer of Molecular Pathology Laboratory Network in Maryville, TN.  His special interests include neoplastic hematopathology, molecular diagnostics and FISH in oncology, and clinical trial laboratory testing. He is a member of American Society for Clinical Pathology and Association for Molecular Pathology.

  • Henry Y. Dong, MD, PhD

    Director, Hematopathology and Molecular Pathology
    Co-Discipline Director, Molecular Oncology, Labcorp

    Dr. Dong is board certified in anatomic pathology and hematopathology. He earned his medical degree from Beijing Medical University and his PhD in molecular cell biology from the Albert Einstein College of Medicine. He was a postdoctoral research fellow at the Dana Farber Cancer Institute. Dr Dong completed his pathology residency at Massachusetts General Hospital followed by a Vickery fellowship in surgical pathology and a James Homer fellowship in hematopathology.

    Dr. Dong is the director of hematopathology and molecular pathology for Integrated Oncology in New York. He has been with Integrated Oncology since 2004. He has published over 30 peer-reviewed articles in major pathology/ scientific journals and has had over 50 abstracts/presentations in major national and international meetings.

  • Vatsala Bhardwaj, MD, PhD

    Anatomic pathology and hematopathology

    Dr. Bhardwaj is board certified in anatomic pathology and hematopathology. She earned her medical degree from the University of Ibadan, Nigeria, and received her PhD in immunology from the National Institute for Medical Research in the United Kingdom. She completed her residency in anatomic pathology at Barnes Hospital in St. Louis and a fellowship in hematopathology at Cornell Medical Center. Dr. Bhardwaj is a member of the American Society for Clinical Pathology, the American Society of Hematology, and the Society for Hematopathology.

  • Pauline Brenholz, MD

    Director, Cytogenetics Oncology

    Dr. Brenholz is board certified in pediatrics, clinical genetics and cytogenetics.  She earned her medical degree, completed her pediatric internship and residency as well as post-doctoral fellowship in medical genetics all at the Albert Einstein College of Medicine, Bronx, NY.  She is a founding fellow of the American College of Medical Genetics and Genomics. She has more than 30 years experience in cytogenetic oncology. Dr. Brenholz has co-authored more than 30 articles and abstracts that have appeared in peer-reviewed publications.  

  • Michael Broscius, MD

    Anatomic and clinical pathology

    Dr. Broscius is board certified in anatomic and clinical pathology. He earned his medical degree from Jefferson Medical College in Philadelphia and completed his residency in anatomic and clinical pathology at Thomas Jefferson University Hospital and Hahnemann Hospital in Pennsylvania. He completed a fellowship in oncologic surgical pathology under the direction of Dr. Juan Rosai at the Memorial Sloan-Kettering Cancer Center. Prior to joining Integrated Oncology, Dr. Broscius served as Medical Director and Director of Immunohistochemistry of a large private laboratory.  Dr. Broscius is a member of the American Society for Clinical Pathology and the College of American Pathologists. His special interests include soft tissue pathology, breast pathology, neoplastic dermatopathology, prostatic pathology, pulmonary pathology, gastrointestinal pathology and germ cell neoplasms.

  • Peijie Cong, MD, PhD

    Anatomic pathology, clinical pathology, and hematopathology

    Dr. Cong is board certified in anatomic pathology, clinical pathology, and hematopathology. He earned his medical degree from the Fourth Military Medical University in Xi’an, China, and his PhD in molecular biology from the Cornell University Graduate School of Medical Sciences. Dr. Cong completed his residency in anatomic and clinical pathology at the University of Chicago Hospitals and completed a fellowship in hematopathology at the National Institutes of Health with Dr Elaine Jaffe.

  • Jiachun Kung, MD, PhD

    Anatomic pathology, clinical pathology, and hematopathology

    Dr. Kung is board certified in anatomic pathology, clinical pathology, and hematopathology. She earned her medical degree from the Shanghai Second Medical University in China and her PhD in biochemistry from the University of Vermont. She completed her residency in anatomic and clinical pathology at Creighton University in Omaha, Nebraska, and Saint Barnabas Medical Center in Livingston, New Jersey. Dr. Kung was a postdoctoral research fellow at the Howard Hughes Medical Institute at Washington University, St. Louis, and completed a hematopathology fellowship at the Cleveland Clinic Foundation. Dr. Kung has authored more than a dozen publications in peer-reviewed medical journals and was a contributing author to the book entitled Manual of Molecular and Clinical Laboratory Immunology, 7th edition.

  • Lin Li, MD, PhD

    Anatomic and clinical pathology

    Dr. Li is board certified in anatomic and clinical pathology. She earned her medical degree from Sun Yat-sen University of Medical Sciences in Guangzhou, China, and completed her residency in anatomic and clinical pathology at North Shore University Hospital in Long Island, New York. She completed a fellowship in genitourinary at the University of Rochester School of Medicine in New York. Dr. Li is a member of the College of American Pathologists and the International Society of Urological Pathology. She holds a special interest in genitourinary pathology, general pathology, as well as Oncologic pathology, particularly molecular and immunohistochemical markers related to prediction of therapeutic and/or prognostic value for cancer.

  • Maomi Li, MD, PhD

    Anatomic pathology

    Dr. Li is board certified in anatomic pathology. He earned his medical degree from Sun Yat-sen University of Medical Sciences in Guangzhou, China, and his PhD in biological chemistry from the University of Michigan. He completed his residency in anatomic pathology at Yale-New Haven Hospital and fellowships in oncologic pathology and experimental pathology at Memorial Sloan-Kettering Cancer Center, where he worked with Dr. Juan Rosai. Dr. Li currently holds an academic appointment at the Albert Einstein College of Medicine as a clinical associate professor of pathology. He specializes in surgical pathology of tumors of the kidney, testis, prostate, bladder, colon, breast, pancreas, and endocrine organs such as thyroid and adrenal glands. Dr. Li has authored more than 40 publications in peer-reviewed medical journals.

  • Augusto Felix Paulino, MD

    Anatomic and clinical pathology

    Dr. Paulino is board certified in anatomic and clinical pathology. He earned his medical degree from the University of the Philippines and completed his residency in pathology at Brown University. He completed fellowships in oncologic pathology and head and neck pathology at Memorial Sloan-Kettering Cancer Center (MSKCC). While at MSKCC, Dr. Paulino also trained in bone pathogy under Dr. Andrew Huvos. He subsequently handled the sarcoma service and the head and neck pathology while working at the University of Michigan. Dr. Paulino has written numerous publications related to tumors of the head and neck region. He is the co-author of the Salivary Glands chapter in the 3rd and 4th editions of Sternberg’s Diagnostic Surgical Pathology.

  • Jeffrey A. Schrager, MD

    Anatomic pathology and hematopathology

    Dr. Schrager is board certified in anatomic pathology and hematopathology. He earned his medical degree from Dartmouth Medical School in Hanover, New Hampshire, and pursued HIV basic research as a postdoctoral fellow at the National Institutes of Health. He completed his residency in anatomic pathology, followed by fellowships in hematopathology and flow cytometry, at the National Cancer Institute. In addition to pathology Dr. Schrager also has a passion in wellness.  In 2017 he became board certified by the American Board of Lifestyle Medicine. Dr. Schrager is a coauthor of the chapter entitled Flow Cytometric Analysis in the Diagnosis and Prognosis of Lymphoma and Chronic Leukemias in Flow Cytometry in Clinical Diagnosis, 4th edition and medical editor of Diagnostic Pathology:  Spleen, published in 2014.

  • Veena Suri, PhD

    Director, Cytogenetics

    Dr. Suri is board certified in clinical cytogenetics.  She earned a PhD PH.D. from Panjab University, Chandigarh, India in 1975 in the faculty of Science and Mathmatics.  Dr. Suri holds qualification from New York State in Cytogenetics and Oncology (Molecular and Cellular Tumor Markers, limited to FISH)  and is a founding fellow of the American College of Medical Genetics.  She has co-authored more than 25 abstracts and articles published in peer-reviewed publications.  Dr. Suri has over 30 years of employment history within our company as a cytogenetic laboratory director. 

  • C. Daniel Wu, MD

    Anatomic and clinical pathology

    Dr. Wu is board certified in anatomic and clinical pathology. He earned his medical degree from the Taipei Medical University School of Medicine in Taiwan. Dr. Wu completed his residency in anatomic and clinical pathology at Brown University-Rhode Island Hospital and was a fellow in hematopathology under the direction of Dr. Jeffrey Medeiros at Brown University, followed by lymphoma expert Dr. Dennis Weisenburger at the University of Nebraska Medical Center. He is a member of the American Society for Clinical Pathology, the United States and Canadian Academy of Pathology, and the Society of Hematopathology. Dr. Wu’s special interest includes lowgrade B-cell lymphoproliferative disorders.

  • Yusong Yang, MD, PhD

    Anatomic pathology and hematopathology

    Dr Yang is board certified in anatomic pathology, clinical pathology, and hematopathology. He earned his medical degree from Nanjing Medical University in China and his PhD in pharmacology and toxicology from the University of Texas Medical Branch at Galveston. He completed his residency in anatomic and clinical pathology at the State University of New York Downstate Medical Center, where he served as a chief resident. He was a dermatology resident at the Institute of Dermatology-Chinese Academy of Medical Sciences in Nanjing, China, and completed a hematopathology fellowship at the Hospital of the University of Pennsylvania in Philadelphia. He has published a number of articles several related to endothelial cell response to oxidative stress, serum paraproteins, and PD-1/PD-L1 expression in cutaneous T cell lymphoma.

  • Ronald J. Paler, Jr, MD

    Medical Director, IHC Discipline Director, Phoenix

    Dr. Paler is board certified in anatomic pathology and cytopathology. He earned his medical degree from Wayne State University School of Medicine in Detroit, Michigan. He completed his residency in anatomic pathology and a cytopathology fellowship at the Los Angeles County University of Southern California Medical Center. Dr. Paler is a former member of the College of American Pathologists’ House of Delegates representing California. He has a special interest in information technology within the field of pathology as well as in quality improvement initiatives within the laboratory setting with emphasis on ISO 15189. Dr. Paler is a member of the CAP 15189 Committee, the American Society of Clinical Pathology, the College of American Pathologists, and the United States and Canadian Academy of Pathology.

  • Beth Braunhut, MD

    Anatomic pathology and clinical pathology

    Dr. Braunhut is board certified in anatomic and clinical pathology.  She earned her medical degree and completed her residency in anatomic and clinical pathology at the University of Arizona College of Medicine, Tucson, Arizona.  She completed fellowships in renal pathology (University of Chicago) and genitourinary pathology (Univeristy of Miami). Dr. Braunhut has co-authored more than 14 articles and abstracts that have appeared in peer-reviewed publications.

  • Eduardo Cantu, PhD

    Director, Cytogenetics

    Dr. Cantu is board certified in clinical cytogenetics.  He earned a PhD in Genetics and Developmental Biology from the University of Michigan, was a Postdoctoral Scholar in the Human Cytogenetics Laboratory at the University of Hawaii, School of Medicine, and completed a medical genetics fellowship at Baylor College of Medicine, Houston, Texas.

  • Neslihan Cetin, MD

    Anatomic pathology, clinical pathology, and hematopathology

    Dr. Cetin is board certified in anatomic pathology, clinical pathology, and hematopathology. She earned her medical degree from the Uludag University Medical School, Bursa, Turkey. She completed her residency in anatomical and clinical pathology, as well as fellowships in hematopathology at the University of Arkansas for Medical Sciences (UAMS), Little Rock, Arkansas, and surgical pathology at New York University (NYU). Dr. Cetin has co-authored more than 25 articles and abstracts published in peer-reviewed publications. Dr. Cetin is a member of the American Medical Association, the College of American Pathologists, the American Society of Clinical Pathologists, the United States and Canadian Academy of Pathology, the Society for Pediatric Pathology, and the Society for Hematopathology. 

  • Perry Chan, PhD, JD

    Director, Molecular

    Dr. Chan is board certified in clinical molecular genetics and molecular diagnostics.  He is also ASCP-certified in microbiology, molecular pathology and laboratory management. Furthermore, he is an ASQ-certified quality auditor and quality manager. He continues to hold an active California law license and USPTO patent attorney license. He received a PhD in in biochemistry from the University of Hong Kong, a juris doctor degree from Concord Law School, and a master degree in quality management from Loyola University at New Orleans.  He completed a clinical genetics fellowship at Columbia University, New York and a post-doctoral fellowship at Albert Einstein College of Medicine.  In addition to authoring a number of book chapters, Dr. Chan has authored more than 20 articles and abstracts for peer-reviewed journals.  Dr. Chan was a past director for American Board of Clinical Chemistry and is currently a CLSI committee member to revise NGS guidelines.

  • Dhan Laxmi Desai, MD

    Anatomic pathology

    Dr. Dhan Laxmi Desai is board certified in anatomic pathology. She earned her medical degree and masters in Pathology from Osmania Medical College/Osmania General Hospital in Hyderabad, India, where she also served as a tutor and assistant professor of pathology from 1983 to 1995. She completed her residency in anatomic and clinical pathology at Metro Health Medical Center in Cleveland, Ohio and a pediatric pathology fellowship at Akron Children’s Hospital in Akron, Ohio. Dr Desai also previously served as a pathologist at both Medina General Hospital, a Cleveland Clinical Hospital and University Hospital, Case Western Medical Center in Cleveland, Ohio. She is a member of the College of American Pathologists.

  • Radwa A. ElBehery, MD

    Anatomic pathology, clinical pathology and hematopathology

    Dr. Radwa ElBehery is board certified in anatomic pathology, clinical pathology and hematopathology.  She earned her medical degree from the Faculty of Medicine, Ain Shams University, Cairo, Egypt, where she also completed her internship, residency in clinical pathology, and received her master’s degree. She completed her fellowship in clinical pathology at Universite De Bretagne Occidental, Brest, France.  Dr. ElBehery completed her residency program training in anatomic pathology/clinical pathology, and hematopathology fellowship training at the University of Nebraska Medical Center. She is a member of the American  society for clinical pathology (ASCP).

  • Froilan P. Espinoza, MD

    Anatomic pathology, clinical pathology, and immunopathology

    Dr. Espinoza is board certified in anatomic pathology, clinical pathology, and immunopathology. He earned his medical degree from the University of California, Irvine School of Medicine. Dr. Espinoza completed his residency in pathology through a combined program at the University of California, Irvine Medical Center, Veterans Affairs Medical Center, and Long Beach Memorial Medical Center. He completed a fellowship in surgical pathology at the University of California, Irvine Medical Center. Dr Espinoza is a member of the College of American Pathologists and held a faculty appointment as assistant clinical professor in the Department of Pathology at the University of California, Irvine School of Medicine (1991-2006).

  • Lee J. McGhan, MD

    Anatomic pathology, clinical pathology, and hematopathology

    Dr. McGhan is board certified in anatomic pathology, clinical pathology, and hematopathology.  He received his medical degree from the Univeristy of Wales, College of Medicine, UK.  He completed an internship in general surgery at Mayo Clinic, Phoenix, AZ, a residency in anatomic and clinical pathology at St. Joseph's Hospital and Medical Center, Phoenix, AZ, and a fellowship in hematopathology at Banner - Univeristy Medical Center, Tuscon, AZ.  In addition to authoring a number of peer-reviewed journal articles and abstracts, Dr. McGhan has given poster and oral presentations at multiple national meetings as well as co-authoring a textbook chapter.  He is also a Fellow of the College of American Pathologists.

  • Lakshmi Nemana, PhD

    Director, Cytogenetics

    Dr. Nemana is board certified in clinical cytogenetics.  She received a PhD in Human Genetics from the Post Graduate Institute of Basic Medical Sciences, University of Madras, Madras, India.  Dr. Nemana is a member of the American College of Medical Genetics, the American Society of Human Genetics and the American Board of Medical Genetics.  She has co-authored more than 14 articles that have appeared in peer-reviewed publications.

  • Dorna Rezania, MD

    Anatomic pathology, clinical pathology, and hematopathology

    Dr. Rezania is board certified in anatomic pathology, clinical pathology, and hematopathology.  She earned her medical degree from the Isfahan University of Medical Science in Iran.  Dr. Rezania completed her residency in anatomic and clinical pathology at the Yale University affiliated, Danbury Hospital in Danbury, CT and fellowships in oncology surgical pathology and hematopathology at the University of South Florida, Moffitt Cancer Center,Tampa, FL.  She is a member of the college of American pathologist.

  • Sassan Rostami, MD

    Director, Hematopathology

    Dr. Rostami is board certified in anatomic pathology, clinical pathology, and hematopathology. He earned his medical degree from the Tehran University of Medical Sciences in Iran. He completed his residency in anatomic and clinical pathology at the University of Pittsburgh and the Harbor-UCLA Medical Center in Torrance, California. He completed a fellowship in hematopathology at the University of California, Los Angeles Medical Center under lymphoma expert Dr. Jonathan Said. Dr. Rostami is a member of the American Society for Clinical Pathology and has a special interest in myelodysplastic syndromes.

  • Arthur Somoza, MD

    Anatomic pathology, clinical pathology, and molecular pathology

    Dr. Somoza is board certified in anatomic pathology and clinical pathology.  He earned his medical degree from the University of Sint Eustatius School of Medicine, Cole Bay, Sint Maarten and completed his residency in anatomic pathology and laboratory medicine at the University of Cincinnati, Cincinnati, OH.  Dr. Somoza completed a fellowship in surgical pathology at the University of New Mexico, Albuquerque, NM and a fellowship in molecular pathology at the University of Arizona, Tucson, AZ.  He is a member of the College of American Pathologists, the American Society for Clinical Pathology, the American Medical Association, and the United States & Canadian Academy of Pathology.

  • Jadwiga Szymanska, PhD

    Director, Cytogenetics

    Dr. Szymanska holds board certification in clinical cytogenetics from the American Board of Medical Genetics and Genomics (ABMGG). She received a PhD degree in cancer cytogenetics from the University of Helsinki School of Medicine, Helsinki, Finland.  Her thesis research project on soft tissue tumors implementing conventional cytogenetics, as well as fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH) resulted in five original publications in the peer-reviewed scientific journals. She completed a post-doctoral fellowship at the Ohio State University (Comprehensive Cancer Center, Division of Human Cancer Genetics), Columbus, OH. Her research concentrated on germ cell tumors. Next, she completed a post-doctoral fellowship at the ABMG accredited training program in Clinical Cytogenetics at the Indiana University School of Medicine, Indianapolis, IN.  Dr. Szymanska is an experienced clinical cytogeneticist with an expertise in cancer cytogenetics, as well as constitutional studies, including prenatal and postnatal cytogenetic diagnostic. She is a fellow of the American College of Medical Genetics and Genomics (ACMGG) and a member of the American Society of Human Genetics (ASHG). Dr. Szymanska has co-authored more than 50 articles and abstracts that have appeared in peer-reviewed publications.

  • Horacio G. Vall, CLS, SCYM(ASCP) Doctor of Biochemistry

    Vice President of Science and Technology
    Discipline Director, Flow Cytometry, LabCorp

    Dr. Vall is a board-certified clinical laboratory scientist (CLS) and holds a Specialty Cytometry (SCYM) certification from the American Society for Clinical Pathology. He received his doctorate at the National University of Rosario, Argentina. Prior to joining Integrated Oncology (formerly US LABS), a member of the LabCorp Specialty Testing Group, Dr Vall served for 3 years as vice president of laboratory services at Clarient, Inc., where he was responsible for developing and implementing specific tests on flow cytometry, molecular oncology, and FISH using conventional and new ways to improve laboratory’s efficiencies and work flow. Prior to that, Dr. Vall worked for Genzyme (formerly Impath) for 8 years, where, as the Corporate Technical Director for high complexity testing, he was responsible for new technologies involving flow cytometry, image analysis, and complex molecular-based testing. He was also responsible for the overall management of all clinical laboratory testing, operations, and test development for the division, and led the QA & QC team in assessment and development of the product pipeline and technology utilization.

    During the early 1990s Dr. Vall worked on leukemia-lymphoma flow cytometry analysis and helper/suppressor studies in transplant patient for drug monitoring, conducted studies on immunodeficiency patients using flow cytometry, and performed stem cell studies for autologous bone marrow transplants at both Loma Linda University Medical Center and City of Hope National Medical Center.

    Dr. Vall is a member of the Clinical Cytometry Society and the Rheumatoid Society.

Center for Molecular Biology and Pathology (CMBP)

  • Arundhati Chatterjee, MD

    Medical Director, Research Triangle Park
    Sub-specialty Medical Director, Uropathology, Dianon Pathology

    Dr. Chatterjee is board certified in anatomic pathology, clinical pathology, and cytopathology. She earned her medical degree from the University of Calcutta, India, and completed her pathology residency in anatomic and clinical pathology followed by a fellowship in surgical pathology and cytopathology at the University of Ottawa, Canada. Dr. Chatterjee’s experience includes serving as pathologist and chief of clinical pathology at Womack Army Medical Center, Fort Bragg, North Carolina, during which time she developed a special interest in uropathology and worked with the Armed Forces Institute of Pathology. Dr. Chatterjee has extensive diagnostic experience in surgical pathology  including uropathology and urine cytology.

  • Rachel D. Burnside, PhD

    Director, Cytogenetics

    Dr. Burnside is board certified in clinical cytogenetics.  She earned a PhD in Microbiology, Immunology, and Molecular Genetics from the University of Kentucky and completed an ABMGG Clinical Cytogenetics Fellowship at the Univeristy of Alabama at Birmingham.  Dr. Burnside has co-authored more than 40 abstracts and articles that have appeared in perr-reviewed journals.  She is a fellow of the American College of Medical Genetics and Genomics and holds memberships with the American Board of Medical Genetics and Genomics, Diplomate, Clinical Cytogenetics, American Society of Human Genetics, American Society of Hematology, and Cancer Genomics Consortium.

  • Li Cai, PhD

    Discipline Director, Molecular Oncology

    Dr. Cai is board certified in clinical molecular genetics by the American Board of Medical Genetics and Genomics, and holds certification in molecular genetic testing and oncology (molecular and cellular tumor markers) from the New York State Department of Health.  She earned a PhD in Genetics, Texas A&M University, Texas and completed her fellowship in clinical molecular genetics at Harvard University, Boston, MA.  Dr. Cai has co-authored more than 35 articles and abstracts that have appeared in peer-reviewed publications and holds patent for her gene discovery research. She has more than 25 years experience in genetics research and development.

  • Anjen Chenn, MD, PhD

    Discipline Director, Molecular Oncology

    Dr. Chenn is board certified in clinical pathology and molecular genetic pathology. He earned his undergraduate degree in biochemical sciences at Harvard University and his MD and PhD in neurosciences from Stanford University. He completed his residency in clinical pathology at the Brigham and Women's Hospital in Boston, Massachusetts, and post-doctoral training in the lab of Dr. Christopher Walsh at Beth Israel Deaconess Medical Center in Boston, and was an instructor at Harvard Medical School. Dr Chenn was a faculty member at Northwestern University Feinberg School of Medicine and served as the director of molecular diagnostics at Northwestern Memorial Hospital in Chicago. Most recently, Dr. Chenn was a tenured associate professor of pathology at the University of Illinois, Chicago, where his research lab focused on understanding developmental brain disorders and brain cancer. Dr. Chenn's laboratory received funding from NIH (NINDS, NCI), Sontag Foundation for Brain Tumor Research, Searle Scholars Program, March of Dimes, Simons Foundation for Autism Research Initiative, and the V Foundation.

  • Inder Gadi, PhD

    Director, Cytogenetics

    Dr. Gadi is board certified in clinical cytogenetics.  He earned a PhD in zoology and cytogenetics from Banaras H. University, Varanasi, India.  He completed a postdoctoral fellowships at the Zoological Society of San Diego, University of California, San Diego and at the Dana Farber Cancer Institute, Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston.  Dr. Gadi is a member of the American Society of Human Genetics and has co-authored over 100 abstracts and articles for peer-reviewed publications.

  • Peter Papenhausen, PhD

    Technical Director, Cytogenetics

    Dr. Papenhausen is board certified in clinical cytogenetics.  He earned a PhD in immunology/genetics from New York University and completed a postdoctoral fellowship at Postdoctoral Researchat Mount Sinai Medical Center, New York. Dr. Papenhausen is a founding fellow of the American College of Medical Genetics and holds memberships to the American Society of Human Genetics, New York Academy of Science, Children’s Oncology Group (COG), South Estern Oncology Group (SWOG), and the Eastern Cooperative Oncology Group (ECOG) Cytogenetics.  Dr. Papenhausen has co-authored over 175 abstracts and publications and served as the National Director of Cytogenetics for LabCorp for over 20 years.

  • Katie Rudd, PhD, FACMG

    Director, Cytogenetics

    Dr. Rudd graduated from the College of William and Mary with Highest Honors in Biology. She worked as a Cytogenetic technologist at Brigham and Women’s Hospital before earning a PhD in Genetics from Case Western Reserve University, where she researched human centromeres. Dr. Rudd completed a Cytogenetics fellowship at the University of Washington and a Molecular Genetics fellowship split between Emory and Duke Universities. Dr. Rudd was an Assistant Professor of Genetics and Senior Director of Cytogenetics at Emory University for eight years before joining LabCorp as a Technical Director. She is certified by the American Board of Medical Genetics and Genomics in Clinical Cytogenetics and Clinical Molecular Genetics, and she holds NY State licenses for Cytogenetics, Genetic Testing, and Oncology: Molecular and Cellular Tumor Markers. 

  • Justin Schleede, PhD

    Genomics Associate Technical Director, Clinical Cytogenetics

    Dr. Schleede is board certified in clinical cytogenetics.  He earned a PhD in genetics and completed a postdoctoral fellowship in cytogenetics at the University of Wisconsin-Madison.  Dr. Schleede is a diplomate of the American Board of Medical Genetics and a fellow of the American College of Medical Genetics.  He has co-authored a number of abstracts and articles that have appeared in peer-reviewed journals.  

  • Stuart Schwartz, PhD

    Discipline Director, Cytogenetics

    Dr. Schwartz is board certified in medical genetics, clinical cytogenetics, and clinical molecular genetics. He earned a PhD in medical genetics from Indiana University and completed a postdoctoral fellowship at the University of Maryland School of Medicine. His major areas of interest include molecular cytogenetics, the delineation and characterization of neocentromeres, phenotype/karyotype correlation in the 9p deletion syndrome, the etiology of structural chromosome abnormalities, the characterization of de novo and complex reciprocal translocations, and high-resolution chromosome methodology. In addition to authoring a number of book chapters, Dr. Schwartz has authored more than 160 articles for peer-reviewed journals.

  • James H. Tepperberg, PhD

    Director, Cytogenetics and Discipline Director, FISH

    Dr. Tepperberg holds board certification in cytogenetics from the American Board of Medical Genetics and in cytogenetics and oncology molecular detection from the New York State Department of Health. He earned a PhD in genetics and developmental biology from West Virginia University with thesis research at Duke University. He received his postdoctoral training in cytogenetics at the University of North Carolina at Chapel Hill.  He has authored a number or articles and abstracts that have appeared in peer-reviewed publications

    Responsibilities at LabCorp include discipline director FISH,  chromosome/ FISH diagnosis and interpretation of prenatal, postnatal, and oncology samples; development and expansion of FISH and single-nucleotide polymorphism (SNP) microarray techniques and analysis; and literature review for related cytogenetic cases and responsibilities.

  • Jonathan L. Klein, MD

    Medical Director, Integrated Oncology and Dianon Pathology, Shelton

    Dr. Klein is board certified in anatomic and clinical pathology, hematopathology and molecular genetic pathology.  He earned his medical degree from Sackler School of Medicine, New York State program, Tel Aviv, Israel. He completed his residency in Anatomic and Clinical Pathology at Winthrop University Hospital, Mineola NY, where he served as chief resident and performed his fellowship training in Hematopathology and Molecular Genetic Pathology at Washington University – Barnes Jewish Hospital, St. Louis MO.  Dr. Klein previously served as laboratory director and chief medical officer of Molecular Pathology Laboratory Network in Maryville, TN.  His special interests include neoplastic hematopathology, molecular diagnostics and FISH in oncology, and clinical trial laboratory testing. He is a member of American Society for Clinical Pathology and Association for Molecular Pathology.

  • Lisa Louise Brailey, MD

    Director, Molecular Pathology

    Dr. Brailey is board certified in clinical molecular genetics, clinical cytogenetics, and medical genetics. She majored in biology at Harvard University, received her medical degree from the University of Connecticut, and did her residency training at the University of North Carolina and Yale University. She also completed fellowships in molecular diagnostics and cytogenetics at Yale. She is a fellow of the American College of Medical Genetics and serves on the board of directors of the New England Regional Genetics Group.  She also is a director for the Naugatuck Valley Health District. Before coming to Dianon, Dr Brailey was associate director of cytogenetics at AmeriPath Northeast.

  • Weiwen Deng, PhD, FACMG

    Director, Clinical Cytogenetics

    Dr. Deng is certified by the American Board of Medical Genetics and Genomics (ABMGG) in Clinical Cytogenetics (FACMG), the American Society for Clinical Pathology (ASCP) in Cytogenetics (CG) and Molecular Biology (MB), and the American Board of Bioanalysis (ABB) as a high-complexity clinical laboratory director in hematology (HCLD). He earned his MD and MS (Microbiology & Immunology) degrees from Shanghai Medical University in China, and PhD degree (molecular & cellular biology) from Tulane University in New Orleans. Dr. Deng published over 20 research papers and book chapters in virology, cancer immunotherapy, stem cell therapy, hematology/oncology, and clinical cytogenetics fields and was awarded 1 U.S. patent. Dr. Deng received his clinical cytogenetics fellowship training in Providence Sacred Heart Medical Center/Signature Genomics in Spokane, Washington. Prior to joining Dianon Pathology, Dr. Deng worked for Kaiser Permanente San Jose Medical Center in California.

  • Suha Mishalani, MD

    Subspecialty Co-director of Hematopathology

    Dr. Mishalani is board certified in anatomic and clinical pathology and hematology. She received her medical degree from the American University of Beirut, Lebanon. Dr. Mishalani joined Dianon Pathology from Cedars Sinai Medical Center in Los Angeles, where she completed her residency and hematopathology subspecialty training and was chief resident. She has extensive training and experience in hematopathology and flow cytometry.

  • Glenn H. Segal, DO

    Subspecialty Co-director of Hematopathology

    Dr. Segal is board certified in anatomic and clinical pathology and hematology. After graduating from the University of Medicine and Dentistry of New Jersey, he was a resident and chief resident at the Cleveland Clinic Foundation and a hematopathology fellow at the University of Utah School of Medicine. Before joining Dianon Pathology, Dr. Segal was an assistant professor of pathology and medical director of the molecular hematopathology laboratory at the University of Utah School of Medicine. He has also been an assistant professor of pathology at the University of Florida College of Medicine in Gainesville. Dr. Segal is the recipient of numerous research awards and has authored more than 25 publications in hematopathology.